Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice
Supriti Samantaray, Varduhi H. Knaryan, Donald C. Shields, et al.
Molecular Neurobiology (2015) Vol. 52, Iss. 2, pp. 1054-1066
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Protective effect of calpain inhibitors against manganese-induced toxicity in rats
Irina S. Ivleva, Andrey P. Ivlev, Nina S. Pestereva, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 4, pp. 1003-1013
Closed Access | Times Cited: 9
Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
Vandana Zaman, Kelsey P. Drasites, Ali Myatich, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13849-13849
Open Access | Times Cited: 9
Early CALP2 expression and microglial activation are potential inducers of spinal IL-6 up-regulation and bilateral pain following motor nerve injury
Shao‐Xia Chen, Shaokun Wang, Peiwen Yao, et al.
Journal of Neurochemistry (2018) Vol. 145, Iss. 2, pp. 154-169
Open Access | Times Cited: 16
Motor Neurons Pathology After Chronic Exposure to MPTP in Mice
Giorgio Vivacqua, Francesca Biagioni, Carla L. Busceti, et al.
Neurotoxicity Research (2019) Vol. 37, Iss. 2, pp. 298-313
Closed Access | Times Cited: 15
Postnatal calpeptin treatment causes hippocampal neurodevelopmental defects in neonatal rats
Guoqi Zhu, Zhujin Song, Sanjuan Yang, et al.
Neural Regeneration Research (2019) Vol. 14, Iss. 5, pp. 834-834
Open Access | Times Cited: 14
Demencia y deterioro cognitivo leve en la enfermedad de Parkinson: una revisión
Yamile Bocanegra García, Natalia Trujillo, David Antonio Pineda Salazar
Revista de Neurología (2014) Vol. 59, Iss. 12, pp. 555-555
Closed Access | Times Cited: 13
Molecular Changes in Sub-lesional Muscle Following Acute Phase of Spinal Cord Injury
Nakul P. Thakore, Supriti Samantaray, Sook‐Young Park, et al.
Neurochemical Research (2015) Vol. 41, Iss. 1-2, pp. 44-52
Open Access | Times Cited: 12
Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson’s Disease
Danúbia Bonfanti Santos, Dirleise Colle, Eduardo Luiz Gasnhar Moreira, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 2, pp. 1513-1530
Closed Access | Times Cited: 12
Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration
J-Y Hwang, Jong Hwan Lee, Chang-ki Oh, et al.
Cell Death and Disease (2016) Vol. 7, Iss. 6, pp. e2240-e2240
Open Access | Times Cited: 12
Chronic MPTP in Mice Damage-specific Neuronal Phenotypes within Dorsal Laminae of the Spinal Cord
Francesca Biagioni, Giorgio Vivacqua, Gloria Lazzeri, et al.
Neurotoxicity Research (2020) Vol. 39, Iss. 2, pp. 156-169
Open Access | Times Cited: 12
Autophagy-Related Genes in Atherosclerosis
Yuankun Chen, Ao Zeng, Shumiao He, et al.
Journal of Healthcare Engineering (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 11
Introduction to Neurodegenerative Diseases
Reihaneh Seyedebrahimi, Piao Yang, Maryam Azimzadeh, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 25-58
Closed Access | Times Cited: 1
Atractylenolide-I Ameliorates Motor Deficits and Reduces Inflammation of the Spinal Cord by SIRT1/PGC-1α Pathway in MPTP Subacute Mouse Model of Parkinson’s Disease
Ya Gao, Shuyue Li, Jian Zhang, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 1919-1929
Open Access | Times Cited: 1
The Cytomegalovirus protein pUL37×1 targets mitochondria to mediate neuroprotection
Chien‐Tai Hong, Kai‐Yin Chau, Anthony H.V. Schapira
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 10
Cell-Permeable Calpain Inhibitor SJA6017 Provides Functional Protection to Spinal Motoneurons Exposed to MPP+
Supriti Samantaray, Varduhi H. Knaryan, Angelo M. Del Re, et al.
Neurotoxicity Research (2020) Vol. 38, Iss. 3, pp. 640-649
Open Access | Times Cited: 10
Thioredoxin-1 Protects Spinal Cord from Demyelination Induced by Methamphetamine through Suppressing Endoplasmic Reticulum Stress and Inflammation
Lihua Yang, Yinli Guo, Mengbin Huang, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 8
Differential role of calpain-dependent protein cleavage in intermediate and long-term operant memory in Aplysia
Lisa C. Lyons, Jacob S. Gardner, Cassidy T. Lentsch, et al.
Neurobiology of Learning and Memory (2016) Vol. 137, pp. 134-141
Open Access | Times Cited: 7
The Role of CD4+ T Cells in the Immunotherapy of Brain Disease by Secreting Different Cytokines
Jing Wang, Yunrong Nan, Mei Liu, et al.
Journal of Neuroimmune Pharmacology (2022) Vol. 17, Iss. 3-4, pp. 409-422
Closed Access | Times Cited: 5
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modelling of Parkinson’s Disease
Livia Pasquali, Elena Caldarazzo Ienco, Francesco Fornai
(2014), pp. 237-275
Closed Access | Times Cited: 3
The Ca2+-Regulated Enzymes Calpain and Calcineurin in Neurodegenerative Processes and Prospects for Neuroprotective Pharmacotherapy
Varduhi H. Knaryan, F. P. Sarukhanyan
Neuroscience and Behavioral Physiology (2024) Vol. 54, Iss. 1, pp. 27-34
Closed Access
Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report
Raghavendar Chandran, Mollie Capone, Denise Matzelle, et al.
Neurochemical Research (2018) Vol. 43, Iss. 12, pp. 2224-2231
Open Access | Times Cited: 3
Baseline Gait and Motor Function Predict Long-Term Severity of Neurological Outcomes of Viral Infection
Moumita Karmakar, Aracely A. Pérez Gómez, Raymond J. Carroll, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2843-2843
Open Access | Times Cited: 1
Ca2+-regulated enzymes calpain and calcineurin in neurodegenerative processes and prospects for neuroprotective pharmacotherapy
Varduhi H. Knaryan, F. P. Sarukhanyan
S S Korsakov Journal of Neurology and Psychiatry (2023) Vol. 123, Iss. 7, pp. 32-32
Closed Access | Times Cited: 1
An adverse outcome pathway for chemical-induced Parkinson’s disease: Calcium is key
Julia J. Meerman, Juliette Legler, Aldert H. Piersma, et al.
NeuroToxicology (2023) Vol. 99, pp. 226-243
Open Access | Times Cited: 1
Calpain inhibition reduces NMDA receptor rundown in rat substantia nigra dopamine neurons
Jerry Zhao, Michel Baudry, Susan Jones
Neuropharmacology (2018) Vol. 137, pp. 221-229
Open Access | Times Cited: 2

Scroll to top